Boston Scientific Corp (BSX)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 1,591,000 1,282,000 966,000 956,000 752,000 653,000 884,000 810,000 1,041,000 884,000 310,000 -23,000 -353,000 -514,000 -233,000 68,000 481,000 614,000 920,000 1,321,000
Total assets US$ in thousands 35,136,000 34,043,000 33,601,000 32,892,000 32,469,000 31,947,000 32,189,000 32,337,000 32,229,000 31,877,000 31,168,000 30,900,000 30,777,000 30,845,000 30,823,000 30,113,000 30,565,000 26,756,000 24,309,000 23,802,000
ROA 4.53% 3.77% 2.87% 2.91% 2.32% 2.04% 2.75% 2.50% 3.23% 2.77% 0.99% -0.07% -1.15% -1.67% -0.76% 0.23% 1.57% 2.29% 3.78% 5.55%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,591,000K ÷ $35,136,000K
= 4.53%

Boston Scientific Corp.'s return on assets (ROA) has shown some variability over the past eight quarters, ranging from a low of 1.87% in Q3 2022 to a high of 4.47% in Q4 2023. On average, the company has achieved an ROA of 2.69% over this period. A rising trend in ROA from Q1 2022 to Q4 2023 indicates an improvement in the company's ability to generate profits from its assets. This suggests that Boston Scientific Corp. has been effectively utilizing its assets to generate earnings for its shareholders, reflecting positively on the company's operational efficiency and financial performance. However, it is important to continue monitoring changes in ROA to assess the sustainability of this performance in the long term.


Peer comparison

Dec 31, 2023


See also:

Boston Scientific Corp Return on Assets (ROA) (Quarterly Data)